Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (HKG:6990)
Hong Kong · Delayed Price · Currency is HKD 412.60
-6.00 (-1.43%)
Last updated: Feb 16, 2026, 11:59 AM HKT
HKG:6990 Market Cap
HKG:6990 has a market cap or net worth of 96.21 billion as of February 13, 2026. Its market cap has increased by 150.94% in one year.
Market Cap
96.21B
Enterprise Value
91.41B
Revenue
1.64B
Ranking
n/a
PE Ratio
n/a
Stock Price
412.60
Market Cap Chart
Since July 11, 2023, HKG:6990's market cap has increased from 13.49B to 96.21B, an increase of 613.25%. That is a compound annual growth rate of 112.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 16, 2026 | 96.21B | 5.20% |
| Dec 31, 2025 | 91.46B | 146.43% |
| Dec 31, 2024 | 37.11B | 64.54% |
| Dec 29, 2023 | 22.56B | 67.21% |
| Jul 11, 2023 | 13.49B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 299.38B |
| WuXi Biologics | 165.50B |
| Innovent Biologics | 153.74B |
| Sino Biopharmaceutical | 116.56B |
| Akeso | 97.00B |
| 3SBio | 58.44B |
| RemeGen | 56.85B |
| Shanghai Henlius Biotech | 38.23B |